HIGH-AFFINITY OF QUINIDINE FOR A STEREOSELECTIVE MICROSOMAL BINDING-SITE AS DETERMINED BY A RADIORECEPTOR ASSAY

被引：10

作者：

OTTON, SV ^{[1
]}

KALOW, W ^{[1
]}

SEEMAN, P ^{[1
]}

机构：

[1] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA

来源：

EXPERIENTIA | 1984年 / 40卷 / 09期

关键词：

D O I：

10.1007/BF01946465

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

收藏

页码：973 / 974

页数：2

相关论文

共 23 条

[1] ALVAN G, 1982, LANCET, V1, P333
[2] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[3] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[4] EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER
DAVIES, DS
KAHN, GC
MURRAY, S
BRODIE, MJ
BOOBIS, AR
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) : 89 - 91
[5] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
EICHELBAUM, M
BERTILSSON, L
SAWE, J
ZEKORN, C
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
[6] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[7] COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE
INABA, T
VINKS, A
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) : 394 - 399
[8] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE
INABA, T
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 547 - 549
[9] LEFKOWITZ RJ, 1978, FED PROC, V37, P123
[10] OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE
LENNARD, MS
SILAS, JH
FREESTONE, S
RAMSAY, LE
TUCKER, GT
WOODS, HF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) : 1558 - 1560